Vigil Neuroscience to Present at 2023 Morgan Stanley Global Healthcare Conference
08 Setembro 2023 - 8:05AM
Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage
biotechnology company committed to harnessing the power of
microglia for the treatment of neurodegenerative diseases, today
announced that members of the management team will participate in a
fireside chat at the 2023 Morgan Stanley Global Healthcare
Conference in New York City on Monday, September 11, 2023, at 9:20
a.m. ET.
To access the live event, please click here to
register for the webcast. The archived webcast will also be
available on the Company’s website under the “Events &
Presentations” page in the “Investors” section for approximately 90
days following the presentation.
About Vigil NeuroscienceVigil
Neuroscience is a clinical-stage biotechnology company focused on
developing treatments for both rare and common neurodegenerative
diseases by restoring the vigilance of microglia, the sentinel
immune cells of the brain. We are utilizing the tools of modern
neuroscience drug development across multiple therapeutic
modalities in our efforts to develop precision-based therapies to
improve the lives of patients and their families. VGL101, our lead
clinical candidate, is a fully human monoclonal antibody agonist
targeting human triggering receptor expressed on myeloid cells 2
(TREM2) in people with adult-onset leukoencephalopathy with axonal
spheroids and pigmented glia (ALSP), a rare and fatal
neurodegenerative disease. We are also developing a novel small
molecule TREM2 agonist to treat common neurodegenerative diseases
associated with microglial dysfunction, with an initial focus on
Alzheimer’s disease (AD) in genetically defined subpopulations.
Investor Contact:Leah Gibson Vice President,
Investor Relations & Corporate CommunicationsVigil
Neuroscience, Inc.lgibson@vigilneuro.com
Media Contact:Megan McGrathMacDougall
Advisorsmmcgrath@macdougall.bio
Vigil Neuroscience (NASDAQ:VIGL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vigil Neuroscience (NASDAQ:VIGL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024